home / stock / pstv / pstv short
Short Information | PLUS THERAPEUTICS Inc. (NYSE:PSTV)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 83,096 |
Total Actual Volume | 1,295,024 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 4,155 |
Average Short Percentage | 5.82% |
Is there a PSTV Short Squeeze or Breakout about to happen?
See the PSTV Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $2.15 | $2.23 | $2.29 | $2.15 | 51,911 | 1,157 | 2.23% |
02-11-2020 | $2.15 | $2.18 | $2.20 | $2.10 | 25,939 | 1,268 | 4.89% |
02-10-2020 | $2.17 | $2.165 | $2.1994 | $2.12 | 21,896 | 708 | 3.23% |
02-07-2020 | $2.24 | $2.17 | $2.24 | $2.16 | 29,417 | 4,655 | 15.82% |
02-06-2020 | $2.22 | $2.21 | $2.24 | $2.1356 | 40,541 | 2,772 | 6.84% |
02-05-2020 | $2.29 | $2.23 | $2.30 | $2.15 | 39,597 | 1,925 | 4.86% |
02-04-2020 | $2.21 | $2.26 | $2.30 | $2.10 | 60,207 | 7,864 | 13.06% |
02-03-2020 | $2.16 | $2.20 | $2.26 | $2.15 | 34,621 | 616 | 1.78% |
01-31-2020 | $2.15 | $2.18 | $2.24 | $2.1387 | 51,183 | 369 | 0.72% |
01-30-2020 | $2.25 | $2.21 | $2.29 | $2.10 | 79,714 | 5,479 | 6.87% |
01-29-2020 | $2.34 | $2.27 | $2.3497 | $2.23 | 55,807 | 2,208 | 3.96% |
01-28-2020 | $2.32 | $2.32 | $2.39 | $2.31 | 24,819 | 525 | 2.12% |
01-27-2020 | $2.30 | $2.33 | $2.40 | $2.19 | 41,151 | 450 | 1.09% |
01-24-2020 | $2.49 | $2.33 | $2.50 | $2.26 | 159,828 | 13,204 | 8.26% |
01-23-2020 | $2.50 | $2.495 | $2.5599 | $2.42 | 29,533 | 2,348 | 7.95% |
01-22-2020 | $2.59 | $2.50 | $2.6569 | $2.50 | 86,220 | 1,462 | 1.7% |
01-21-2020 | $2.66 | $2.5665 | $2.80 | $2.51 | 115,931 | 2,350 | 2.03% |
01-17-2020 | $2.75 | $2.71 | $2.86 | $2.68 | 83,694 | 7,273 | 8.69% |
01-16-2020 | $2.70 | $2.72 | $2.94 | $2.6915 | 117,831 | 12,872 | 10.92% |
01-15-2020 | $2.80 | $2.7204 | $2.80 | $2.61 | 145,184 | 13,591 | 9.36% |
News, Short Squeeze, Breakout and More Instantly...
PLUS THERAPEUTICS Inc. Company Name:
PSTV Stock Symbol:
NYSE Market:
Median overall survival (mOS) in 15 patients with recurrent glioblastoma (rGBM) from the Phase 2 study is 13 months, which is 63% better than current standard of care (bevacizumab monotherapy) of 8 months; 9 of the 15 patients remain alive Median progression free survival (mPFS) is 11 mon...
AUSTIN, Texas, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical compa...
AUSTIN, Texas, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced it ...